Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05325788 · ClinicalTrials.gov registry record · NA

Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05325788: Completed NA study, sponsored by Yale University.

NCT05325788 is a NA study that has completed, run by Yale University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05325788, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This project aims to improve the health of individuals engaged in co-occurring alcohol and opioid use by supporting the maintenance of behavior change initiated in substance use treatment. Building on prior research, this study will entail a stage 1b pilot to test the feasibility and acceptability of an app-based intervention for individuals reporting co-occurring alcohol and opioid use. The intervention will involve modifying an app currently used in a research study to collect GPS information to send push notifications when individuals encounter self-identified place-based triggers. Thirty individuals completing substance use treatment will consent to use the app for a thirty-day pilot period and will complete assessments of intervention feasibility and acceptability. Using within-subject tests, the analysis will summarize participant responses to assessments and will compare the use of general messaging to place-specific messaging.

Primary Outcome

Feasibility is assessed by average time spent using the app, measured through app usage metrics. More time spent using the app indicates more engagement.

Interventions

  • OTHER e-Covery
  • OTHER Comparator Condition

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-11-04
Est. Completion 2023-11-07
Phase NA
Yale University

1,492 total trials

What the finished NCT05325788 record still lists

NCT05325788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which e-Covery is the first listed.

NCT05325788 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05325788 about?

NCT05325788 is a clinical study titled "Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use". This project aims to improve the health of individuals engaged in co-occurring alcohol and opioid use by supporting the maintenance of behavior change initiated in substance use treatment. Building on prior research, this study will entail a stage 1b pilot to test the feasibility and acceptability o...

What is the current status of trial NCT05325788?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-11-04. Estimated completion is 2023-11-07.

What interventions are being tested in trial NCT05325788?

The interventions under investigation include: e-Covery (OTHER), Comparator Condition (OTHER).

Who is sponsoring clinical trial NCT05325788?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05325788's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05325788, the US trial registry maintained by the National Library of Medicine. NCT05325788 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.